<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"><identifier identifierType="DOI">10.7939/DVN/10959</identifier><creators><creator><creatorName nameType="Personal">Richer, Lawrence</creatorName><givenName>Lawrence</givenName><familyName>Richer</familyName><nameIdentifier nameIdentifierScheme="ORCID">0000-0002-6897-8668</nameIdentifier><affiliation>University of Alberta</affiliation></creator></creators><titles><title>Efficacy of Combination Therapy with Intravenous Ketorolac and Metoclopramide for Pediatric Migraine Therapy in the Emergency Department</title><title titleType="AlternativeTitle">Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department</title></titles><publisher>UAL Dataverse</publisher><publicationYear>2016</publicationYear><subjects><subject>Medicine, Health and Life Sciences</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">emergency departments</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">pediatrics</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">metoclopramide</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">ketorolac</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">intravenous injections</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">emergencies</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">randomized controlled trial</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">migraine disorders</subject><subject schemeURI="https://www.nlm.nih.gov/mesh/" subjectScheme="MeSH">headache disorders</subject></subjects><contributors><contributor contributorType="ContactPerson"><contributorName nameType="Personal">Richer, Lawrence</contributorName><givenName>Lawrence</givenName><familyName>Richer</familyName><affiliation>University of Alberta</affiliation></contributor><contributor contributorType="Producer"><contributorName nameType="Personal">Richer, Lawrence</contributorName><givenName>Lawrence</givenName><familyName>Richer</familyName><affiliation>University of Alberta</affiliation></contributor></contributors><dates><date dateType="Created">2012</date><date dateType="Updated">2017-05-29</date><date dateType="Collected">2012-02/2014-04</date></dates><resourceType resourceTypeGeneral="Dataset">Interview data; Clinical data</resourceType><alternateIdentifiers><alternateIdentifier alternateIdentifierType="ClinicalTrials.gov">NCT01596166</alternateIdentifier></alternateIdentifiers><sizes><size>18257</size></sizes><formats><format>application/vnd.openxmlformats-officedocument.spreadsheetml.sheet</format></formats><version>2.2</version><rightsList><rights rightsURI="info:eu-repo/semantics/openAccess"/><rights/></rightsList><descriptions><description descriptionType="Abstract">The purpose of this study is to investigate whether the combination of ketorolac (an anti-inflammatory pain medication) and metoclopramide (an anti-nauseant that may also relieve migraine headaches) is better than metoclopramide by itself when treating children in the Emergency Department.</description></descriptions><geoLocations><geoLocation><geoLocationPlace>Edmonton, Alberta</geoLocationPlace></geoLocation></geoLocations><fundingReferences><fundingReference><funderName>Canadian Institutes of Health Research (CIHR)</funderName></fundingReference></fundingReferences></resource>